celecoxib has been researched along with Active Hyperemia in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Whether the chronic administration of HMG-CoA reductase inhibitors provides similar protection remains controversial and is unknown in humans." | 2.77 | Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study. ( Gori, T; Liuni, A; Luca, MC; Parker, JD, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luca, MC | 2 |
| Liuni, A | 2 |
| McLaughlin, K | 1 |
| Gori, T | 2 |
| Parker, JD | 2 |
| Konger, RL | 1 |
| Xu, Z | 1 |
| Sahu, RP | 1 |
| Rashid, BM | 1 |
| Mehta, SR | 1 |
| Mohamed, DR | 1 |
| DaSilva-Arnold, SC | 1 |
| Bradish, JR | 1 |
| Warren, SJ | 1 |
| Kim, YL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Remote Ischaemic Conditioning on Blood Pressure Control in Patients With Chronic Kidney Disease - the ERIC-BP-CKD Trial[NCT03236350] | 85 participants (Anticipated) | Interventional | 2017-11-28 | Recruiting | |||
| A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)[NCT02506062] | 21 participants (Actual) | Interventional | 2015-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for celecoxib and Active Hyperemia
| Article | Year |
|---|---|
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Topics: Adult; Analysis of Variance; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2013 |
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Topics: Adult; Analysis of Variance; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2013 |
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Topics: Adult; Analysis of Variance; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2013 |
Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
Topics: Adult; Analysis of Variance; Celecoxib; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2013 |
Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.
Topics: Adolescent; Adult; Analysis of Variance; Blood Flow Velocity; Celecoxib; Cyclooxygenase 2 Inhibitors | 2012 |
1 other study available for celecoxib and Active Hyperemia
| Article | Year |
|---|---|
Spatiotemporal assessments of dermal hyperemia enable accurate prediction of experimental cutaneous carcinogenesis as well as chemopreventive activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Carcinogens; Celecoxib; Cell Tr | 2013 |